GLYCOS BIOTECHNOLOGIES

Glycos Biotechnologies, Inc. enables the fuels and chemicals industries of the future. Their partners can flexibly make high value products from a wide range of non-food feedstocks, increasing profits and reducing carbon footprint. They partner with ethanol companies, biodiesel companies and chemical companies interested in leveraging existing infrastructure into alternative chemicals and fuels production. They are also collaborating with biorefinery manufacturers and plant operators to deliver the technology for an integrated biorefinery solution.
GLYCOS BIOTECHNOLOGIES
Industry:
Biotechnology Chemical Renewable Energy
Founded:
2007-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.glycosbio.com
Total Employee:
11+
Status:
Active
Contact:
713-869-9377
Email Addresses:
[email protected]
Total Funding:
19.39 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Mobile Non Scaleable Content Google Apps For Business AJAX Libraries API Google Google Cloud
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Genomatica
Genomatica manufactures sustainable chemicals from renewable feedstocks.
Newlight Technologies
Newlight Technologies is a biotechnology company producing advanced sustainable materials.
Codex DNA
Codex DNA is a biology company helping researchers with the tools they need to securely design, code, and create synthetic DNA.
Zymochem
Zymochem provides a carbon-efficient bio-manufacturing platform that converts renewable feedstocks into bio-based materials.
Current Advisors List
Current Employees Featured
Founder
Investors List
Texas HALO Fund
Texas HALO Fund investment in Seed Round - Glycos Biotechnologies
DFJ Mercury
DFJ Mercury investment in Debt Financing - Glycos Biotechnologies
Threshold
Threshold investment in Debt Financing - Glycos Biotechnologies
DFJ Mercury
DFJ Mercury investment in Debt Financing - Glycos Biotechnologies
EIV Capital
EIV Capital investment in Series B - Glycos Biotechnologies
DFJ Mercury
DFJ Mercury investment in Series B - Glycos Biotechnologies
DNX Ventures
DNX Ventures investment in Series B - Glycos Biotechnologies
Threshold
Threshold investment in Series B - Glycos Biotechnologies
Gideon Hixon Fund
Gideon Hixon Fund investment in Series B - Glycos Biotechnologies
Threshold
Threshold investment in Series A - Glycos Biotechnologies
Official Site Inspections
http://www.glycosbio.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147

More informations about "Glycos Biotechnologies"
Home | GlycosBio, Inc.
GlycosBio is focused on research and development to improve the therapeutic performance of natural bioactive molecules to the body using engineered lipid technologies. The concept of โฆSee details»
Glycos Biotechnologies - Crunchbase Company Profile
Organization. Glycos Biotechnologies . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email โฆSee details»
GlycosBio, Inc. - LinkedIn
GlycosBio, Inc. Biotechnology Research Houston, Texas 1,016 followers Clinically Driven - Personalized Care for a Healthy MicrobiomeSee details»
GlycosBio Company Profile 2024: Valuation, Funding
GlycosBio General Information Description. Developer of nutritional products designed to support specific medical needs. The company's nutritional products are more easily absorbed and โฆSee details»
Contact Us | GlycosBio, Inc.
Unlocking the Therapeutic Value of Natural Materials. GlycosBio. Copyright © 2023 GlycosBio, Inc.See details»
Glycos Biotechnologies - Overview, News & Similar โฆ
Glycos Biotechnologies, Inc. (GlycosBio) is an international biochemical company focused on the commercialization of advanced metabolic engineering and microbial strain development which โฆSee details»
GlycosBio - Company Profile - Tracxn
Nov 7, 2024 GlycosBio is a scientifically focused biotechnology company with expertise in molecular biology as well as metabolic engineering. The company leverages metabolic โฆSee details»
Lipid Engineering - GlycosBio, Inc.
GlycosBioโs lipid engineering technologies harness the innate bioactive qualities in natural lipid structures to help Clients modernize OTC consumer and personal care products. Our Mission โฆSee details»
GlycosBio - Products, Competitors, Financials, Employees, โฆ
Aug 20, 2011 GlycosBio has a specific interest in synthetic rubber intermediates including bio-derivedisoprene. Solixโs crude algal oil was found to be non-toxic and easily metabolized and โฆSee details»
GlycosBio Food Sciences - VentureRadar
GlycosBio is a food science company that develops and produces advanced nutritional products. We apply the principles of human nutrition and biotechnology to produce scientifically tested, โฆSee details»
Glycos Biotechnologies - Craft
GlycosBio is a food science company that develops and produces advanced nutritional products. Its products address specific dietary deficiencies in individuals with varying health conditions. โฆSee details»
Richard Cilento - FibroBiologics
Richard C. Cilento, Jr. Board of Directors Mr. Cilento has served on our board of directors since April 2021. Mr. Cilento is the founder, Chairperson of the board of directors and Chief โฆSee details»
BiotechCorp Grants BioNexus Status to GlycosBio - Crop โฆ
Feb 25, 2011 GlycosBio is presently constructing an industrial biochemical plant and biotechnology research and development facility in Bio-XCell, a dedicated biotechnology park โฆSee details»
Glycos Biotechnologies - EquityNet
Glycos Biotechnologies, Inc. enables the fuels and chemicals industries of the future. Their partners can flexibly make high value products from a wide range of non-food feedstocks, โฆSee details»
Enhanced Delivery Research | GlycosBio, Inc.
GlycosBio has developed a library of lipids designed to significantly enhance the permeability of molecules through the skin to improve the performance of target molecules. With the advice of โฆSee details»
Glycos Biotech Raises $5 Million - venturecapitaljournal.com
Apr 19, 2009 Glycos Biotechnologies, Inc. (GlycosBio) announced the closing of a $5.0 million Series A round of financing led by venture capital firms Draper Fisher Jurvetson (DFJ) and โฆSee details»
Glycos Biotechnologies, Inc. Closes Series A Round of $5 โฆ
Apr 17, 2009 Glycos Biotechnologies, Inc. (GlycosBio) announced the closing of a $5.0 million Series A round of financing led by venture capital firms Draper Fishe.See details»
GlycosBio Careers and Employment | Indeed.com
Jun 10, 2015 Find out what works well at GlycosBio from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular โฆSee details»
Bioavailability Research | GlycosBio, Inc.
Clinical Study: PERT-Free Nutrition, Cystic Fibrosis We designed and clinically tested the first medical food specifically designed for cystic fibrosis patients that bypasses the need for โฆSee details»
Microbiota Research | GlycosBio, Inc.
GlycosBio's scientific team is dedicated to the development of elemental natural products that address microbiota dysbiosis. The concept of selectively influencing the intestinal, pulmonary, โฆSee details»